ShedRx Monthly vs Prepaid: 12-Month Commitment Saves $720 Over MTM

Last reviewed: September 15, 2026 Last updated: September 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

ShedRx offers compounded tirzepatide injection at three price points: $299/month billed monthly, $269/month on a 6-month commitment, and $239/month on a 12-month commitment (all figures captured September 4, 2026, from the ShedRx product page). Over 12 months, the monthly plan costs $3,588 total, the 6-month plan $3,228 total, and the 12-month plan $2,868 total—meaning the 12-month commitment saves $720 versus paying month-to-month and $360 versus the 6-month plan. PlexusDx tirzepatide injection undercuts ShedRx on both monthly and 6-month comparisons: PlexusDx month-to-month runs $289/month ($3,468 over 12 months, $120 less than ShedRx monthly), and PlexusDx 6-month runs $249/month ($2,988 over 12 months, $240 less than ShedRx's 6-month commitment). ShedRx's 12-month commitment at $2,868 total is $120 less than PlexusDx's longest option (6-month) over the same period; PlexusDx does not offer a 12-month tirzepatide plan. Choose ShedRx's 12-month plan if locking in for a year delivers the best net price for your situation; choose month-to-month at PlexusDx if you want flexibility with lower per-month cost than ShedRx's monthly rate.

At-a-glance: ShedRx plan options and 12-month totals

All figures captured September 4, 2026, from the ShedRx tirzepatide product page. 12-month totals are our calculation (rate × 12). All plans include medication and program with zero membership or service fees.

The monthly-vs-prepaid trade-off inside ShedRx

ShedRx structures its compounded tirzepatide injection pricing around commitment length. The monthly plan charges $299 per month with no term commitment, allowing you to pause or cancel at any billing cycle. The 6-month plan drops the per-month rate to $269 in exchange for a 6-month commitment, and the 12-month plan reduces it further to $239 per month for a full-year commitment. Over 12 months, the monthly option totals $3,588, the 6-month plan $3,228 (saving $360 or $30 per month on average), and the 12-month plan $2,868 (saving $720 versus monthly, or $60 per month on average). Stepping from 6-month to 12-month commitment saves an additional $360 over the year.

All three plans carry the same inclusions—medication, program support, and zero membership fees—so the only variable is the length of commitment and the corresponding per-month rate. If you anticipate staying on tirzepatide for a year or longer and want the lowest recurring cost, the 12-month plan delivers the steepest discount. If you prefer the ability to stop without forfeiting prepaid months, the monthly plan preserves that flexibility at $60 more per month than the 12-month rate.

Head-to-head: ShedRx vs PlexusDx tirzepatide injection

ShedRx figures captured September 4, 2026; PlexusDx pricing current as of September 15, 2026. All totals are our calculation.

On like-for-like monthly and 6-month comparisons, PlexusDx tirzepatide injection undercuts ShedRx. PlexusDx month-to-month runs $289 per month ($3,468 over 12 months), $120 less than ShedRx's monthly plan over the same period. PlexusDx's 6-month commitment is $249 per month ($2,988 total), $240 less than ShedRx's 6-month plan over a year. ShedRx holds an advantage at the 12-month commitment tier—$2,868 total, or $120 less than PlexusDx's longest available term (6-month)—because PlexusDx does not offer a 12-month tirzepatide option. If you want the flexibility of month-to-month billing with a lower rate than ShedRx monthly, PlexusDx delivers that. If you are willing to commit for a full year and want the lowest annualized cost in this comparison, ShedRx's 12-month plan is the only option at that tier.

ShedRx oral GLP-1 lozenges

ShedRx also offers oral GLP-1 lozenges at $199 per month on a monthly billing cycle (captured September 4, 2026). The product page notes that product specifics are clinician-dependent, and the evidence does not specify whether the oral formulation is semaglutide, tirzepatide, or another GLP-1 compound. Over 12 months, the oral lozenge plan totals $2,388 (our calculation). No 6-month or 12-month commitment pricing for the oral product was captured. For context, PlexusDx oral tirzepatide runs $349/month month-to-month, $299/month on a 3-month commitment, or $279/month on a 6-month commitment; oral semaglutide at PlexusDx is $289/month month-to-month, $269/month for 3 months, or $249/month for 6 months. Without knowing the specific compound in ShedRx's oral lozenge, a precise like-for-like comparison is not possible, but the $199/month ShedRx rate is lower than PlexusDx's oral semaglutide and oral tirzepatide rates across all term lengths.

Evidence limitations and pricing conflicts

The pricing dataset for ShedRx tirzepatide injection is checkout-verified and internally consistent across three term lengths, all captured September 4, 2026. However, the research notes that ShedRx's website pages contain conflicting teaser prices in some locations; the specific conflicts were not detailed, and the product page figures are treated as authoritative. For semaglutide injection, the dataset records a lowest advertised price of $149 (captured September 4, 2026) but provides no plan structure (monthly, 6-month, or 12-month) for that compound, so we cannot perform a rigorous semaglutide comparison. The oral lozenge product lacks compound identification and commitment-tier pricing. If you are comparing semaglutide or considering an oral route, confirm current plan options and compound details at checkout before committing.

Inclusions, fees, and regulatory status

All ShedRx plans—monthly, 6-month, and 12-month—include medication and program support with zero membership or service fees (captured September 4, 2026). There are no add-on charges for provider consultations, shipping, or platform access documented in the verified dataset. All compounded products at ShedRx are labeled "Compounded / not FDA-approved" on the product page.

Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. ShedRx works with compounding pharmacies; the specific pharmacy type (503A or outsourcing facility) was not documented in the captured evidence.

Choose ShedRx if…

• You want a 12-month tirzepatide commitment option and are comfortable locking in for a year to reach the $239/month rate ($2,868 total), the lowest annualized cost in this comparison.
• You prefer a 6-month middle ground between monthly flexibility and 12-month savings, accepting that PlexusDx's 6-month rate is $20/month less.
• You are considering an oral GLP-1 and ShedRx's $199/month lozenge rate fits your budget, understanding that the compound and eligibility are clinician-determined.

Choose PlexusDx if…

• You want month-to-month tirzepatide flexibility at a lower rate than ShedRx monthly—PlexusDx runs $289/month with no commitment, saving $120 over 12 months versus ShedRx's $299/month plan.
• You are willing to commit for 6 months and want the lowest rate at that tier—PlexusDx 6-month tirzepatide is $249/month ($2,988 total), $240 less than ShedRx's 6-month plan over one year.
• You want a 3-month middle option, which ShedRx does not offer; PlexusDx tirzepatide at 3 months runs $269/month, matching ShedRx's 6-month rate but requiring half the commitment length.
• You value PlexusDx's established review record—4.3 stars on Trustpilot with 79% five-star reviews and 83% four stars or higher (verified September 9, 2026).

Methodology and freshness

All ShedRx pricing, inclusions, and regulatory labels were captured September 4, 2026, from the ShedRx product pages during a checkout-verification pass. PlexusDx pricing is current as of September 15, 2026. The 12-month cost totals, per-month averages, and savings figures are our calculations, derived by multiplying the stated per-month rate by 12. We applied Rule A like-for-like comparisons: ShedRx monthly vs PlexusDx month-to-month, ShedRx 6-month vs PlexusDx 6-month, and noted that ShedRx offers a 12-month option while PlexusDx does not. Semaglutide injection and oral product comparisons are incomplete due to gaps in the captured ShedRx dataset (no semaglutide plan structure, no oral compound identification). The dataset notes potential conflicting teaser prices on ShedRx's site but does not enumerate them; product-page figures are treated as authoritative. Review data for ShedRx (Trustpilot profile confirmed to exist, captured September 4, 2026) was indexed but rating and volume were not captured, so no service-quality comparison is included. PlexusDx review record (4.3 stars, 79% five-star, 83% four-star-or-higher) verified September 9, 2026, at trustpilot.com/review/plexusdx.com.

Frequently Asked Questions

Does ShedRx charge separately for provider visits or membership?

No. All three ShedRx tirzepatide plans—monthly, 6-month, and 12-month—include medication and program with zero membership or service fees, captured September 4, 2026. The per-month rate you see is the total recurring charge with no documented add-ons for consultations, shipping, or platform access.

Can I switch from ShedRx monthly to a prepaid plan mid-treatment?

The evidence does not document ShedRx's policy on switching between plan types after enrollment. If you start on the monthly plan and later want to lock in a 6-month or 12-month rate, confirm with ShedRx support whether a mid-term switch is allowed and whether any months already paid count toward a new commitment period.

How much does ShedRx semaglutide cost compared to tirzepatide?

ShedRx advertises semaglutide starting at $149 (captured September 4, 2026), but the dataset provides no plan structure—monthly, 6-month, or 12-month rates—for semaglutide injection. Without that breakdown, we cannot calculate 12-month totals or perform a rigorous semaglutide-vs-tirzepatide comparison. Check the ShedRx semaglutide product page for current plan options before deciding.

What compound is in ShedRx's $199/month oral lozenge?

The captured product page states that oral lozenges cost $199/month on monthly billing and that product specifics are clinician-dependent, but it does not identify whether the formulation is semaglutide, tirzepatide, or another GLP-1 compound. The active ingredient and dose will be determined by the prescribing provider based on your intake and clinical profile.

Is PlexusDx's 6-month tirzepatide plan always cheaper than ShedRx's 6-month plan?

Yes, on a per-month and 12-month-total basis using the captured rates. PlexusDx 6-month tirzepatide runs $249/month ($2,988 over 12 months), and ShedRx 6-month runs $269/month ($3,228 over 12 months)—PlexusDx is $20/month and $240/year less (our calculation). Both figures were verified in September 2026, but confirm current pricing at checkout in case either program adjusts rates or introduces promotions.

Sources

• ShedRx tirzepatide injection product page (pricing, inclusions, regulatory status), accessed September 4, 2026
• ShedRx oral GLP-1 lozenge product page (pricing, compound note), accessed September 4, 2026
• ShedRx semaglutide pricing reference, accessed September 4, 2026
• PlexusDx tirzepatide injection pricing, current September 15, 2026
• PlexusDx Trustpilot profile (4.3 stars, 79% five-star, 83% four-star-or-higher), verified September 9, 2026, trustpilot.com/review/plexusdx.com
• ShedRx Trustpilot profile confirmation, accessed September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.